InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (30 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
30
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Harmon Cyrus, Chief Technology Officer. Officer active across 1 company, notably Olema Pharmaceuticals, Inc.. In total, 32 disclosures have been published. Split: 0 buy · 30 sells. Total volume traded: €5.2m. History available since 18 June 2021. The latest transaction was disclosed on 9 December 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations32 total
29,250 shares0Common StockSEC:0001415889-24-029028:0
4,066 shares@ US$15.581.1% of flowCommon StockSEC:0001415889-24-020461:0
5,000 shares@ US$12.261.1% of flowCommon StockSEC:0001415889-24-019528:0
20,000 shares@ US$10.773.9% of flowCommon StockSEC:0001415889-24-018975:0
15,000 shares@ US$9.412.5% of flowCommon StockSEC:0001415889-24-015508:0
5,000 shares@ US$10.921.0% of flowCommon StockSEC:0001415889-24-012485:0
15,000 shares@ US$9.512.6% of flowCommon StockSEC:0001415889-24-012020:0
20,000 shares@ US$10.973.9% of flowCommon StockSEC:0001415889-24-009445:0
24,900 shares@ US$12.415.5% of flowCommon StockSEC:0001415889-24-006322:0
25,000 shares@ US$12.235.4% of flowCommon StockSEC:0001415889-24-002350:0
22,500 shares@ US$13.305.2% of flowCommon StockSEC:0001415889-24-000070:0
25,000 shares@ US$12.575.5% of flowCommon StockSEC:0001415889-23-015701:0
15,750 shares0Common StockSEC:0001415889-23-015457:0
25,000 shares@ US$12.055.5% of flowCommon StockSEC:0001415889-23-014714:0
25,000 shares@ US$12.415.7% of flowCommon StockSEC:0001415889-23-013898:0
15,000 shares@ US$9.362.5% of flowCommon StockSEC:0001415889-23-012922:0
15,000 shares@ US$10.142.7% of flowCommon StockSEC:0001415889-23-012898:0
15,000 shares@ US$10.142.7% of flowCommon StockSEC:0001415889-23-012360:0
10,000 shares@ US$6.301.1% of flowCommon StockSEC:0001415889-23-009522:0
5,000 shares@ US$6.0450.5% of flowCommon StockSEC:0001415889-23-009406:0
400 shares@ US$24.760.0007% mcap0.4% of flowCommon StockSEC:0001415889-21-005622:0
400 shares@ US$24.760.2% of flowCommon StockSEC:0001415889-21-005622
7,445 shares@ US$27.850.015% mcap8.3% of flowCommon StockSEC:0001415889-21-004934:0
7,445 shares@ US$27.853.4% of flowCommon StockSEC:0001415889-21-004934
12,000 shares@ US$26.300.023% mcap12.5% of flowCommon StockSEC:0001415889-21-004513:0
25 of 32 declarations
About Harmon Cyrus
Cyrus Harmon is the Chief Technology Officer (CTO) of Olema Pharmaceuticals, Inc. In this role, he is responsible for leading the company's technology initiatives. His expertise in technology and innovation is crucial for the development of new products and solutions. He plays a key role in the strategic direction of Olema Pharmaceuticals, Inc.
